Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.46 USD | -1.96% | -19.05% | -17.12% |
Jan. 14 | Leerink Partners Adjusts Moderna Price Target to $27 From $31, Maintains Underperform Rating | MT |
Jan. 14 | Stocks Gain Pre-Bell Ahead of Latest PPI Report; Asia, Europe Strong | MT |
Highlights
Jan. 14 | MT | |
Jan. 14 | MT | |
Jan. 13 | RE | |
Jan. 13 | DJ | |
Jan. 13 | MT | |
Jan. 13 | MT | |
Jan. 13 | MT | |
Jan. 13 | MT | |
Jan. 13 | MT | |
Jan. 13 | MT | |
Jan. 13 | MT | |
Jan. 13 | MT | |
Jan. 13 | MT | |
Jan. 13 | CF | |
Jan. 13 | MT | |
Jan. 13 | MT | |
Jan. 13 | RE | |
Jan. 08 | DJ | |
Jan. 08 | MT | |
Jan. 08 | ||
Jan. 08 | MT | |
Jan. 07 | DJ | |
Jan. 07 | MT | |
Jan. 07 | MT | |
Jan. 07 | MT |
Filters
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Highlights